Mullin, A., & Jean-Claude, B. (2020). HER2/neu Oncogene and Sensitivity to the DNA-Interactive Drug Doxorubicin. McGill Journal of Medicine, 4(1). https://doi.org/10.26443/mjm.v4i1.673